Patients antineoplastic combined chemotherapy protocols. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Tumor Cells, Cultured Bone Marrow HL-60 Cells Cell Line

Organisms6

Mice, Nude Narcissus Aster Plant Olacaceae Mice, Inbred BALB C Mice, SCID

Diseases59

Osteosarcoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Breast Neoplasms Neoplasms Lung Neoplasms Neoplasm Recurrence, Local Ovarian Neoplasms Neoplasm Metastasis Adenocarcinoma Carcinoma, Non-Small-Cell Lung Vomiting Nausea Lymphoma, Non-Hodgkin Colorectal Neoplasms Neutropenia Brain Neoplasms Bone Neoplasms Testicular Neoplasms Leukopenia Leukemia P388 Hodgkin Disease Liver Neoplasms Lymphoma Colonic Neoplasms Carcinoma, Squamous Cell Neoplasms, Germ Cell and Embryonal Carcinoma Recurrence Leukemia, Myeloid, Acute Disease Progression Peritoneal Neoplasms Thrombocytopenia Lymphatic Metastasis Leukemia L1210 Stomach Neoplasms Germinoma Head and Neck Neoplasms Leukemia Neoplasms, Experimental Multiple Myeloma Pancreatic Neoplasms Leukemia, Myeloid Sarcoma Drug-Related Side Effects and Adverse Reactions Glioma Neoplasm, Residual Prostatic Neoplasms Lymphoma, Large B-Cell, Diffuse Retroperitoneal Neoplasms Melanoma Seminoma Mediastinal Neoplasms Stomatitis Phlebitis Sarcoma 180 Central Nervous System Neoplasms Neoplasms, Second Primary Hematologic Diseases Neuroblastoma

Chemicals and Drugs84

Antineoplastic Agents Doxorubicin Cyclophosphamide Cisplatin Vincristine Antibiotics, Antineoplastic Antineoplastic Agents, Phytogenic Etoposide Antineoplastic Agents, Alkylating Paclitaxel Antimetabolites, Antineoplastic Methotrexate Vinblastine Carboplatin Bleomycin Taxoids Ifosfamide Cytarabine Organoplatinum Compounds Deoxycytidine Anthracyclines Daunorubicin Carmustine Camptothecin Lomustine Mitomycin Dacarbazine Melphalan Mitoxantrone Antibodies, Monoclonal, Humanized 6-Mercaptopurine Gallium Tumor Markers, Biological Bryostatins Ellipticines Phospholipid Ethers Granulocyte Colony-Stimulating Factor Floxuridine Antibodies, Monoclonal Thiadiazines Platinum Compounds Antiemetics Thiotepa Tegafur Amaryllidaceae Alkaloids P-Glycoprotein Mitomycins Prodrugs Dexamethasone Epothilones Bibenzyls Vindesine Bridged Compounds Angiogenesis Inhibitors Enzyme Inhibitors Amsacrine Platinum Sulindac Recombinant Proteins Lactones Topotecan Depsipeptides Oxonic Acid Nitrosourea Compounds Antibodies, Monoclonal, Murine-Derived Prednisolone Receptor, erbB-2 Thymidylate Synthase Drug Combinations Neoplasm Proteins RNA, Messenger DNA, Neoplasm Nimustine Mesna Fluorouracil Tumor Suppressor Protein p53 Asparaginase Proto-Oncogene Proteins c-bcl-2 Receptors, Estrogen Nitrogen Mustard Compounds Pyrazines Topoisomerase II Inhibitors Drugs, Investigational Granisetron

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Disease-Free Survival Treatment Outcome Chemotherapy, Adjuvant Prognosis Retrospective Studies Clinical Protocols Neoadjuvant Therapy Drug Administration Schedule Survival Analysis Neoplasm Staging Survival Rate Induction Chemotherapy Drug Screening Assays, Antitumor Clinical Trials as Topic Follow-Up Studies Chemotherapy, Cancer, Regional Perfusion Salvage Therapy Radiotherapy Prospective Studies Infusions, Intravenous Transplantation, Autologous Radiotherapy, Adjuvant Xenograft Model Antitumor Assays Drug Evaluation Antineoplastic Protocols Randomized Controlled Trials as Topic Kaplan-Meier Estimate Infusions, Intra-Arterial Gloves, Protective Hematopoietic Stem Cell Transplantation Neoplasm Transplantation Radiotherapy Dosage Drug Therapy Palliative Care Feasibility Studies Drug Evaluation, Preclinical Neoplasms, Experimental Research Design Immunohistochemistry Administration, Oral Hyperthermia, Induced Pilot Projects Chemoradiotherapy Multivariate Analysis Risk Factors Maintenance Chemotherapy Cranial Irradiation Clinical Trials, Phase III as Topic Inhibitory Concentration 50 Predictive Value of Tests Actuarial Analysis Tomography, X-Ray Computed Protective Devices Tumor Burden Bone Marrow Transplantation Flow Cytometry Drug Delivery Systems Proportional Hazards Models Protective Clothing Equipment and Supplies, Hospital Tumor Stem Cell Assay Fatal Outcome Mastectomy Sensitivity and Specificity Treatment Failure Reproducibility of Results Clinical Trials, Phase II as Topic Consolidation Chemotherapy

Phenomena and Processes18

Drug Resistance, Neoplasm Time Factors Dose-Response Relationship, Drug Apoptosis Drug Synergism Cell Survival Cell Proliferation Drug Resistance, Multiple Gene Expression Regulation, Neoplastic Cell Cycle Cell Division Drug Resistance DNA Damage Inhibitory Concentration 50 Molecular Structure Dental Physiological Processes Drug Interactions Sensitivity and Specificity

Disciplines and Occupations4

Oncology Nursing Research Design Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Technology, Industry, Agriculture4

Gloves, Protective Protective Devices Laundering Protective Clothing

Humanities1

Quality of Life

Information Science2

Survival Rate Fatal Outcome

Named Groups2

Medical Secretaries Nursing Staff, Hospital

Health Care35

Disease-Free Survival Treatment Outcome Retrospective Studies Clinical Protocols Survival Analysis Survival Rate Clinical Trials as Topic Follow-Up Studies Prospective Studies Antineoplastic Protocols Randomized Controlled Trials as Topic Kaplan-Meier Estimate Oncology Nursing Palliative Care Feasibility Studies Occupational Exposure Pilot Projects Multivariate Analysis Risk Factors Clinical Trials, Phase III as Topic Medical Secretaries Predictive Value of Tests Actuarial Analysis Proportional Hazards Models Cancer Care Facilities Oncology Service, Hospital Equipment Contamination Fatal Outcome Decontamination Sensitivity and Specificity Age Factors Treatment Failure Reproducibility of Results Clinical Trials, Phase II as Topic Nursing Staff, Hospital

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care

Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Doxorubicin Cyclophosphamide Osteosarcoma Combined Modality Therapy Cisplatin Disease-Free Survival Vincristine Treatment Outcome Chemotherapy, Adjuvant Prognosis Precursor Cell Lymphoblastic Leukemia-Lymphoma Retrospective Studies Clinical Protocols Antibiotics, Antineoplastic Antineoplastic Agents, Phytogenic Etoposide Breast Neoplasms Neoplasms Neoadjuvant Therapy Antineoplastic Agents, Alkylating Drug Administration Schedule Paclitaxel Antimetabolites, Antineoplastic Lung Neoplasms Methotrexate Survival Analysis Neoplasm Staging Survival Rate Drug Resistance, Neoplasm Vinblastine Carboplatin Bleomycin Time Factors Taxoids Cell Line, Tumor Ifosfamide Cytarabine Organoplatinum Compounds Induction Chemotherapy Drug Screening Assays, Antitumor Dose-Response Relationship, Drug Deoxycytidine Neoplasm Recurrence, Local Anthracyclines Apoptosis Ovarian Neoplasms Daunorubicin Clinical Trials as Topic Neoplasm Metastasis Carmustine Follow-Up Studies Adenocarcinoma Carcinoma, Non-Small-Cell Lung Vomiting Tumor Cells, Cultured Nausea Camptothecin Drug Synergism Lymphoma, Non-Hodgkin Colorectal Neoplasms Neutropenia Chemotherapy, Cancer, Regional Perfusion Salvage Therapy Lomustine Cell Survival Mitomycin Radiotherapy Brain Neoplasms Prospective Studies Dacarbazine Infusions, Intravenous Melphalan Transplantation, Autologous Bone Neoplasms Testicular Neoplasms Leukopenia Radiotherapy, Adjuvant Leukemia P388 Mitoxantrone Hodgkin Disease Xenograft Model Antitumor Assays Drug Evaluation Antineoplastic Protocols Liver Neoplasms Antibodies, Monoclonal, Humanized 6-Mercaptopurine Lymphoma Gallium Randomized Controlled Trials as Topic Colonic Neoplasms Tumor Markers, Biological Carcinoma, Squamous Cell Kaplan-Meier Estimate Cell Proliferation Neoplasms, Germ Cell and Embryonal Carcinoma Bryostatins Ellipticines

No FAQ available that match "patients antineoplastic combined chemotherapy protocols"